Article
Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.
The Journal of clinical investigation - 15 Apr 2021
Raas Quentin, van de Beek Malu-Clair, Forss-Petter Sonja, Dijkstra Inge Me, Deschiffart Abigail, Freshner Briana C, Stevenson Tamara J, Jaspers Yorrick Rj, Nagtzaam Liselotte, Wanders Ronald Ja, van Weeghel Michel, Engelen-Lee Joo-Yeon, Engelen Marc, Eichler Florian, Berger Johannes, Bonkowsky Joshua L, Kemp Stephan
Abstract excerpt
X-linked adrenoleukodystrophy (ALD) is a progressive neurodegenerative disease caused by mutations in ABCD1, the peroxisomal very long-chain fatty acid (VLCFA) transporter. ABCD1 deficiency results in accumulation of saturated VLCFAs. A drug screen using a phenotypic motor assay in a zebrafish ALD model identified chloroquine as the top hit. Chloroquine increased expression of stearoyl-CoA desaturase-1 (scd1),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
